Where innovative Medical Go-To-Market Success is the rule! 

Want to Learn or See More? Click here

Synergistic Marketing, founded in 1990 by Mark Lutvak, is a successful, growing and profitable sales and marketing contracting firm and consultancy. We are dedicated to serving Small Emerging businesses that own or possess Medical Technology or Medical Device IP. We support our clients with a go-to-market strategy that takes advantage of our extensive network of medical industry companies as well as our extensive list of contacts who are our Corporate Partners.

Want to Learn or See More? Click here

 

Medical Technology and Device News Title

  • August 8, 2016:

    University of Florida researchers successfully used functional magnetic resonance imaging to evaluate five areas of the brain that are key to movement and balance. A year after the baseline study, the 46 Parkinson's patients in the study showed declining function in two areas: the primary motor cortex and putamen. Using functional magnetic resonance imaging to track the progression of Parkinson's disease could help evaluate experimental treatments to slow or stop the disease's progression.Full Story

  • August 8, 2016:

    The Food and Drug Administration has released a final guidance document that explains the benefits, risks, planning, and implementation of adaptive clinical study designs used in medical device development. These study designs—which can change as the data rolls in—can be more efficient than traditional, fixed clinical designs, can provide more responsive treatment for enrolled patients, and can better protect the welfare of the test subjects.Full Story

  • August 8, 2016:

    According to RNR Market Research, the global infusion pumps and accessories market is expected to reach USD 10.2 Billion by 2020 at a CAGR of 5.8% over the next few years. The primary reasons include a larger geriatric population with increasing chronic diseases, increased use of pumps at home, and continuing technological improvements. For some patients, small pumps that provide instantaneous monitoring and medicating can eliminate the need for manual injections.Full Story

  • August 4, 2016:

    Researchers presented a new blood test to help identify which patients are at an elevated risk of Alzheimer's disease at the 68th AACC Annual Scientific Meeting & Clinical Lab. This test detects the presence of a protein in the blood produced by a specific variation of the apolipoprotein gene (ApoE4), which is associated with increased risk of developing Alzheimer's disease. It can be inherited from one or both parents and the likelihood of developing Alzheimer increases accordingly.Full Story

  • July 28, 2016:

    Scientists at the University of Maryland School of Medicine have discovered the process for neurotransmission in the brain. Synapses are very complicated molecular machines. They are also tiny: only a few millionths of an inch across. To visualize features on this sub-microscopic scale, researchers have turned to an innovative technology known as single-molecule imaging, which can locate and track the movement of individual protein molecules within the confines of a single synapse, even in living cells. Using this approach, the scientists identified an unexpected and precise pattern in neurotransmission.Full Story

  • July 27, 2016:

    A minimally invasive, nerve ablating procedure, was recently cleared by the Food and Drug Administration. The treatment uses radio frequency energy to disable the targeted-nerve responsible for low back pain. Under local anesthesia with mild sedation, through a small opening in the patient’s back, an access tube is inserted into a specific bony structure of the spine, called a vertebral body; heat is applied; the nerve is disabled.Full Story

  • July 26, 2016:

    In the journal Nature Materials, researchers at MIT describe an adhesive patch that can stick to a tumor site, either before or after surgery, to deliver a triple-combination of drug, gene, and photo (light-based) therapy. The researchers have developed a triple-therapy hydrogel patch, which can be used to treat tumors locally. This is particularly effective as it can treat not only the tumor itself but any cells left at the site after surgery, preventing the cancer from recurring or metastasizing in the future. As the patch degrades, it will gradually release the various therapies.Full Story

  • July 21, 2016:

    A new research funding agreement between the Juvenile Diabetes Research Foundation (JDRF) and Sernova, a clinical-stage regenerative medicine biotech, aims to address people with severe type 1 diabetes (T1D) who are hypoglycemia unaware. They are at a higher risk of acute life threatening consequences that can lead to coma and death following an insulin injection that reduces blood glucose to dangerously low levels. The funding will advance human clinical trials of Sernova’s novel cell macroencapsulated implantable and scalable Cell Pouch System (CPS) with the hope to improve the quality of life and overall outcomes for these patients.Full Story

  • July 21, 2016:

    A collaborative effort between the University of Maryland Medical Center and Harpoon Medical of Baltimore is designed to provide a minimally invasive surgical solution for degenerative mitral regurgitation. Rather than opening the chest, surgery utilizing the Harpoon device enters the heart through a mini-thoracotomy on the left side of the torso, right below the breast. Thus eliminating the need to open the chest cavity and stop the heart beating..Full Story

  • July 21, 2016:

    New findings published by a team of researchers led by Dr. Andres Lozano at the Krembil Neuroscience Centre (KNC) of Toronto Western Hospital (TWH) have provided further insight into the effects of Deep Brain Stimulation (DBS) in the treatment of Alzheimer’s disease. The use of DBS appears to slow cognitive decline and improve the brain’s ability to metabolize glucose.Full Story